Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells
Open Access
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 17 (4) , 550-564
Abstract
No abstract availableKeywords
Funding Information
- HHS NIH National Institute of General Medical Sciences (NIGMS) (R01 GM114594)
This publication has 61 references indexed in Scilit:
- Quantitative Proteomic Profiling Identifies DPYSL3 as Pancreatic Ductal Adenocarcinoma-Associated Molecule That Regulates Cell Adhesion and Migration by Stabilization of Focal Adhesion ComplexPLOS ONE, 2013
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 MutationsNew England Journal of Medicine, 2012
- Specificity of Linear Motifs That Bind to a Common Mitogen-Activated Protein Kinase Docking GrooveScience Signaling, 2012
- Phosphorylation of Stim1 at serine 575 via netrin-2/Cdo–activated ERK1/2 is critical for the promyogenic function of Stim1Molecular Biology of the Cell, 2012
- Antagonistic TSC22D1 variants control BRAFE600‐induced senescenceThe EMBO Journal, 2011
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- Distinct Priming Kinases Contribute to Differential Regulation of Collapsin Response Mediator Proteins by Glycogen Synthase Kinase-3 in VivoJournal of Biological Chemistry, 2006
- Activation and signaling of the p38 MAP kinase pathwayCell Research, 2005
- Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibitionNature Structural & Molecular Biology, 2004